Ratiometric delivery of two therapeutic candidates with inherently dissimilar physicochemical property through pH-sensitive core–shell nanoparticles targeting the heterogeneous tumor cells of glioma

Currently, combination drug therapy is one of the most effective approaches to glioma treatment. However, due to the inherent dissimilar pharmacokinetics of individual drugs and blood brain barriers, it was difficult for the concomitant drugs to simultaneously be delivered to glioma in an optimal do...

Full description

Bibliographic Details
Main Authors: He-Lin Xu, Zi-Liang Fan, De-Li ZhuGe, Meng-Qi Tong, Bi-Xin Shen, Meng-Ting Lin, Qun-Yan Zhu, Bing-Hui Jin, Yasin Sohawon, Qing Yao, Ying-Zheng Zhao
Format: Article
Language:English
Published: Taylor & Francis Group 2018-01-01
Series:Drug Delivery
Subjects:
Online Access:http://dx.doi.org/10.1080/10717544.2018.1474974
_version_ 1818329112366809088
author He-Lin Xu
Zi-Liang Fan
De-Li ZhuGe
Meng-Qi Tong
Bi-Xin Shen
Meng-Ting Lin
Qun-Yan Zhu
Bing-Hui Jin
Yasin Sohawon
Qing Yao
Ying-Zheng Zhao
author_facet He-Lin Xu
Zi-Liang Fan
De-Li ZhuGe
Meng-Qi Tong
Bi-Xin Shen
Meng-Ting Lin
Qun-Yan Zhu
Bing-Hui Jin
Yasin Sohawon
Qing Yao
Ying-Zheng Zhao
author_sort He-Lin Xu
collection DOAJ
description Currently, combination drug therapy is one of the most effective approaches to glioma treatment. However, due to the inherent dissimilar pharmacokinetics of individual drugs and blood brain barriers, it was difficult for the concomitant drugs to simultaneously be delivered to glioma in an optimal dose ratio manner. Herein, a cationic micellar core (Cur-M) was first prepared from d-α-tocopherol-grafted-ε-polylysine polymer to encapsulate the hydrophobic curcumin, followed by dopamine-modified-poly-γ-glutamic acid polymer further deposited on its surface as a anion shell through pH-sensitive linkage to encapsulate the hydrophilic doxorubicin (DOX) hydrochloride. By controlling the combinational Cur/DOX molar ratio at 3:1, a pH-sensitive core–shell nanoparticle (PDCP-NP) was constructed to simultaneously target the cancer stem cells (CSCs) and the differentiated tumor cells. PDCP-NP exhibited a dynamic diameter of 160.8 nm and a zeta-potential of –30.5 mV, while its core–shell structure was further confirmed by XPS and TEM. The ratiometric delivery capability of PDCP-NP was confirmed by in vitro and in vivo studies, in comparison with the cocktail Cur/DOX solution. Meanwhile, the percentage of CSCs in tumors was significantly decreased from 4.16% to 0.95% after treatment with PDCP-NP. Overall, PDCP-NP may be a promising carrier for the combination therapy with drug candidates having dissimilar physicochemical properties.
first_indexed 2024-12-13T12:42:53Z
format Article
id doaj.art-ea3a4d08c54549b992d3b44a5081640b
institution Directory Open Access Journal
issn 1071-7544
1521-0464
language English
last_indexed 2024-12-13T12:42:53Z
publishDate 2018-01-01
publisher Taylor & Francis Group
record_format Article
series Drug Delivery
spelling doaj.art-ea3a4d08c54549b992d3b44a5081640b2022-12-21T23:45:35ZengTaylor & Francis GroupDrug Delivery1071-75441521-04642018-01-012511302131810.1080/10717544.2018.14749741474974Ratiometric delivery of two therapeutic candidates with inherently dissimilar physicochemical property through pH-sensitive core–shell nanoparticles targeting the heterogeneous tumor cells of gliomaHe-Lin Xu0Zi-Liang Fan1De-Li ZhuGe2Meng-Qi Tong3Bi-Xin Shen4Meng-Ting Lin5Qun-Yan Zhu6Bing-Hui Jin7Yasin Sohawon8Qing Yao9Ying-Zheng Zhao10Wenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityCurrently, combination drug therapy is one of the most effective approaches to glioma treatment. However, due to the inherent dissimilar pharmacokinetics of individual drugs and blood brain barriers, it was difficult for the concomitant drugs to simultaneously be delivered to glioma in an optimal dose ratio manner. Herein, a cationic micellar core (Cur-M) was first prepared from d-α-tocopherol-grafted-ε-polylysine polymer to encapsulate the hydrophobic curcumin, followed by dopamine-modified-poly-γ-glutamic acid polymer further deposited on its surface as a anion shell through pH-sensitive linkage to encapsulate the hydrophilic doxorubicin (DOX) hydrochloride. By controlling the combinational Cur/DOX molar ratio at 3:1, a pH-sensitive core–shell nanoparticle (PDCP-NP) was constructed to simultaneously target the cancer stem cells (CSCs) and the differentiated tumor cells. PDCP-NP exhibited a dynamic diameter of 160.8 nm and a zeta-potential of –30.5 mV, while its core–shell structure was further confirmed by XPS and TEM. The ratiometric delivery capability of PDCP-NP was confirmed by in vitro and in vivo studies, in comparison with the cocktail Cur/DOX solution. Meanwhile, the percentage of CSCs in tumors was significantly decreased from 4.16% to 0.95% after treatment with PDCP-NP. Overall, PDCP-NP may be a promising carrier for the combination therapy with drug candidates having dissimilar physicochemical properties.http://dx.doi.org/10.1080/10717544.2018.1474974ratiometric deliverydissimilar pharmacokineticscombination therapyheterogeneitytargeting
spellingShingle He-Lin Xu
Zi-Liang Fan
De-Li ZhuGe
Meng-Qi Tong
Bi-Xin Shen
Meng-Ting Lin
Qun-Yan Zhu
Bing-Hui Jin
Yasin Sohawon
Qing Yao
Ying-Zheng Zhao
Ratiometric delivery of two therapeutic candidates with inherently dissimilar physicochemical property through pH-sensitive core–shell nanoparticles targeting the heterogeneous tumor cells of glioma
Drug Delivery
ratiometric delivery
dissimilar pharmacokinetics
combination therapy
heterogeneity
targeting
title Ratiometric delivery of two therapeutic candidates with inherently dissimilar physicochemical property through pH-sensitive core–shell nanoparticles targeting the heterogeneous tumor cells of glioma
title_full Ratiometric delivery of two therapeutic candidates with inherently dissimilar physicochemical property through pH-sensitive core–shell nanoparticles targeting the heterogeneous tumor cells of glioma
title_fullStr Ratiometric delivery of two therapeutic candidates with inherently dissimilar physicochemical property through pH-sensitive core–shell nanoparticles targeting the heterogeneous tumor cells of glioma
title_full_unstemmed Ratiometric delivery of two therapeutic candidates with inherently dissimilar physicochemical property through pH-sensitive core–shell nanoparticles targeting the heterogeneous tumor cells of glioma
title_short Ratiometric delivery of two therapeutic candidates with inherently dissimilar physicochemical property through pH-sensitive core–shell nanoparticles targeting the heterogeneous tumor cells of glioma
title_sort ratiometric delivery of two therapeutic candidates with inherently dissimilar physicochemical property through ph sensitive core shell nanoparticles targeting the heterogeneous tumor cells of glioma
topic ratiometric delivery
dissimilar pharmacokinetics
combination therapy
heterogeneity
targeting
url http://dx.doi.org/10.1080/10717544.2018.1474974
work_keys_str_mv AT helinxu ratiometricdeliveryoftwotherapeuticcandidateswithinherentlydissimilarphysicochemicalpropertythroughphsensitivecoreshellnanoparticlestargetingtheheterogeneoustumorcellsofglioma
AT ziliangfan ratiometricdeliveryoftwotherapeuticcandidateswithinherentlydissimilarphysicochemicalpropertythroughphsensitivecoreshellnanoparticlestargetingtheheterogeneoustumorcellsofglioma
AT delizhuge ratiometricdeliveryoftwotherapeuticcandidateswithinherentlydissimilarphysicochemicalpropertythroughphsensitivecoreshellnanoparticlestargetingtheheterogeneoustumorcellsofglioma
AT mengqitong ratiometricdeliveryoftwotherapeuticcandidateswithinherentlydissimilarphysicochemicalpropertythroughphsensitivecoreshellnanoparticlestargetingtheheterogeneoustumorcellsofglioma
AT bixinshen ratiometricdeliveryoftwotherapeuticcandidateswithinherentlydissimilarphysicochemicalpropertythroughphsensitivecoreshellnanoparticlestargetingtheheterogeneoustumorcellsofglioma
AT mengtinglin ratiometricdeliveryoftwotherapeuticcandidateswithinherentlydissimilarphysicochemicalpropertythroughphsensitivecoreshellnanoparticlestargetingtheheterogeneoustumorcellsofglioma
AT qunyanzhu ratiometricdeliveryoftwotherapeuticcandidateswithinherentlydissimilarphysicochemicalpropertythroughphsensitivecoreshellnanoparticlestargetingtheheterogeneoustumorcellsofglioma
AT binghuijin ratiometricdeliveryoftwotherapeuticcandidateswithinherentlydissimilarphysicochemicalpropertythroughphsensitivecoreshellnanoparticlestargetingtheheterogeneoustumorcellsofglioma
AT yasinsohawon ratiometricdeliveryoftwotherapeuticcandidateswithinherentlydissimilarphysicochemicalpropertythroughphsensitivecoreshellnanoparticlestargetingtheheterogeneoustumorcellsofglioma
AT qingyao ratiometricdeliveryoftwotherapeuticcandidateswithinherentlydissimilarphysicochemicalpropertythroughphsensitivecoreshellnanoparticlestargetingtheheterogeneoustumorcellsofglioma
AT yingzhengzhao ratiometricdeliveryoftwotherapeuticcandidateswithinherentlydissimilarphysicochemicalpropertythroughphsensitivecoreshellnanoparticlestargetingtheheterogeneoustumorcellsofglioma